The Role of Digital Health in Immuno-oncology Therapy Development and Adoption
Tackling the challenges that come along with the explosive growth in IO
Unlocking improved patient outcomes with digital health solutions
Innovations in cancer therapy are everywhere. This activity is evident within immuno-oncology as new approaches, such as immune checkpoint inhibitors and CAR-T demonstrate their potential. Along with these opportunities come a wealth of challenges that could get in the way of delivering positive patient outcomes, including patient matching, finding actionable, meaningful insights, and access and cost.
Join BrightInsight CEO Kal Patel, M.D., along with Arturo Loaiza-Bonilla, M.D. of the Cancer Treatment Centers of America, and John Lo, Senior VP, Worldwide Hematology of Bristol Myers Squibb as they explore how you can overcome these challenges using digital technologies to:
- Enable more targeted interventions through data
- Improve patient outcomes through precision medicine and better patient matching
- Expand patient access to therapies by easing barriers to clinical trial enrollment and reimbursement
Biopharma and R&D
The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your. The role of digital health in immuno-oncology.